JP2002540769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002540769A5 JP2002540769A5 JP2000601031A JP2000601031A JP2002540769A5 JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5 JP 2000601031 A JP2000601031 A JP 2000601031A JP 2000601031 A JP2000601031 A JP 2000601031A JP 2002540769 A5 JP2002540769 A5 JP 2002540769A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- substantially purified
- purified protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
Description
【特許請求の範囲】
【請求項1】 図1(配列番号 )のアミノ酸配列を含む、実質的に精製されたタンパク質。
【請求項1】 図1(配列番号 )のアミノ酸配列を含む、実質的に精製されたタンパク質。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12210499P | 1999-02-26 | 1999-02-26 | |
US60/122,104 | 1999-02-26 | ||
PCT/US2000/004613 WO2000050453A1 (en) | 1999-02-26 | 2000-02-24 | A novel inhibitor of programmed cell death |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002540769A JP2002540769A (ja) | 2002-12-03 |
JP2002540769A5 true JP2002540769A5 (ja) | 2007-04-26 |
Family
ID=22400634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000601031A Abandoned JP2002540769A (ja) | 1999-02-26 | 2000-02-24 | プログラム細胞死の新規抑制剤 |
Country Status (7)
Country | Link |
---|---|
US (1) | US6570002B1 (ja) |
EP (1) | EP1161444A4 (ja) |
JP (1) | JP2002540769A (ja) |
AU (1) | AU760466B2 (ja) |
CA (1) | CA2363621A1 (ja) |
MX (1) | MXPA01008626A (ja) |
WO (1) | WO2000050453A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100111928A1 (en) * | 1997-05-23 | 2010-05-06 | A & G Pharmaceutical, Inc. | Methods and kits for diagnosis tumorgenicity |
US20030215445A1 (en) | 1997-05-23 | 2003-11-20 | Ginette Serrero | Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
JP4435563B2 (ja) | 2001-07-10 | 2010-03-17 | バイオジェン アイデック インク | アポトーシスプロセスの阻害および細胞性能の改善 |
US7411045B2 (en) * | 2002-11-19 | 2008-08-12 | A&G Pharmaceutical, Inc. | Autocrine growth factor receptor antibodies and methods |
AU2003901010A0 (en) * | 2003-03-06 | 2003-03-20 | Flinders Technologies Pty Ltd | Apoptosis regulator |
EP1644038A2 (en) * | 2003-06-23 | 2006-04-12 | A & G Pharmaceuticals, Inc. | Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis |
EP1660010B1 (en) * | 2003-08-01 | 2013-07-24 | A & G Pharmaceutical, Inc. | Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
JP5317472B2 (ja) * | 2004-03-15 | 2013-10-16 | サネシス ファーマシューティカルズ, インコーポレイテッド | Sns−595、及びその使用方法 |
US8580814B2 (en) * | 2006-04-03 | 2013-11-12 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer |
JP2009539994A (ja) | 2006-06-12 | 2009-11-19 | サネシス ファーマシューティカルズ, インコーポレイテッド | 癌の治療のための化合物及び組成物 |
ES2556677T3 (es) * | 2006-08-02 | 2016-01-19 | Sunesis Pharmaceuticals, Inc. | Utilización combinada de ácido (+)-1,4-dihidro-7-[(3S,4S)-3-metoxi-4-(metilamino)-1-pirrolidinil]-4-oxo-1-(2-tiazolil)-1,8-naftiridin-3-carboxílico y citarabina (Ara-C) para el tratamiento de la leucemia |
WO2009054935A1 (en) * | 2007-10-22 | 2009-04-30 | Sunesis Pharmaceuticals, Inc. | Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy |
CA2990477A1 (en) * | 2015-08-12 | 2017-02-16 | Memorial Sloan-Kettering Cancer Center | Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
US5646008A (en) | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
US5622852A (en) | 1994-10-31 | 1997-04-22 | Washington University | Bcl-x/Bcl-2 associated cell death regulator |
US5539094A (en) | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
ES2256843T3 (es) | 1993-11-30 | 2006-07-16 | Tanox, Inc. | Proteinas con que modulan la apoptosis, adn codante para estas proteinas, y su modo de utilizacion. |
US5858678A (en) | 1994-08-02 | 1999-01-12 | St. Louis University | Apoptosis-regulating proteins |
US5858715A (en) | 1997-01-29 | 1999-01-12 | Incyte Pharmaceuticals, Inc. | Human apoptosis-associated protein |
-
2000
- 2000-02-24 AU AU33740/00A patent/AU760466B2/en not_active Ceased
- 2000-02-24 WO PCT/US2000/004613 patent/WO2000050453A1/en not_active Application Discontinuation
- 2000-02-24 JP JP2000601031A patent/JP2002540769A/ja not_active Abandoned
- 2000-02-24 MX MXPA01008626A patent/MXPA01008626A/es unknown
- 2000-02-24 EP EP00911926A patent/EP1161444A4/en not_active Withdrawn
- 2000-02-24 CA CA002363621A patent/CA2363621A1/en not_active Abandoned
- 2000-02-24 US US09/512,346 patent/US6570002B1/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003515323A5 (ja) | ||
JP2002519061A5 (ja) | ||
JP2004501162A5 (ja) | ||
JP2002540769A5 (ja) | ||
JP2002524024A5 (ja) | ||
AU2001292757A1 (en) | Modified selex processes without purified protein | |
JP2006516098A5 (ja) | ||
WO1998055508A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
JP2003525623A5 (ja) | ||
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
JP2004532624A5 (ja) | ||
JP2004508843A5 (ja) | ||
IL156799A0 (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
JP2006510360A5 (ja) | ||
WO2003020759A3 (en) | A caspase- 8 binding protein, its preparation and use | |
JP2001078180A5 (ja) | ||
DE60126602D1 (de) | Neue collectine | |
WO2001053347A3 (fr) | Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
GB0030309D0 (en) | Antibodies,Peptides,Analogs and uses thereof | |
AU2001236777A1 (en) | 39406 protein, a seven transmembrane protein | |
WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
CA2244928A1 (en) | Dna coding for serine/threonine kinase | |
WO2000042063A3 (de) | Peptide zur inhibierung von hbv-core-proteinen | |
WO2001094417A3 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same |